World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	You J, Zhuang L, Tang BZ, Yang WB, Ding SY, Li W, Wu RX, Zhang HL, Zhang YM, Yan SM, Zhang L. Randomized controlled clinical trial on the treatment of Thymosin-a1 vs interferon-α in patients with hepatitis B. World J Gastroenterol 2001; 7(3): 411-414 [PMID: 11819801 DOI: 10.3748/wjg.v7.i3.411]
URL:	https://www.wjgnet.com/1007-9327/full/v7/i3/411.htm

(0) (0) (0) (4477) (17)

Number	Citing Articles
1	Yui-Jie Bai, Jin-Rong Zhao, Guan-Ting Lv, Wen-Hong Zhang, Yan Wang, Xiao-Jun Yan. Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarization. World Journal of Gastroenterology 2003; 9(10): 2344-2347 doi: 10.3748/wjg.v9.i10.2344 Abstract(1455) \| Core Tip(1224) \| Full Article(HTML)(3787) \| Full Article (PDF)-109K(706) \| Times Cited (0) \| Total Visits (5366) \| Open
2	Xiaoning Wu, Jidong Jia, Hong You. Thymosin alpha-1 treatment in chronic hepatitis B. Expert Opinion on Biological Therapy 2015; 15(sup1) doi: 10.1517/14712598.2015.1007948
3	S. Iino, J. Toyota, H. Kumada, K. Kiyosawa, S. Kakumu, M. Sata, H. Suzuki, E. B. Martins. The efficacy and safety of thymosin alpha‐1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial. Journal of Viral Hepatitis 2005; 12(3) doi: 10.1111/j.1365-2893.2005.00633.x
4	A. Ciancio, M. Rizzetto. Thymalfasin in the treatment of hepatitis B and C. Annals of the New York Academy of Sciences 2010; 1194(1) doi: 10.1111/j.1749-6632.2010.05487.x
5	YUN‐FAN LIAW. Thymalfasin (thymosin‐alpha 1) therapy in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2004; 19(S6) doi: 10.1111/j.1440-1746.2004.03633.x
6	Timothy M. Block, Siddhartha Rawat, Carol L. Brosgart. Chronic hepatitis B: A wave of new therapies on the horizon. Antiviral Research 2015; 121 doi: 10.1016/j.antiviral.2015.06.014
7	Zhen-Wei Lang, Hong-Lei Han. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment. World Journal of Gastroenterology 2003; 9(1): 117-121 doi: 10.3748/wjg.v9.i1.117 Abstract(1226) \| Core Tip(1069) \| Full Article(HTML)(2639) \| Full Article (PDF)-477K(561) \| Times Cited (12) \| Total Visits (4258) \| Open
8	Stephanos J Hadziyannis, George V Papatheodoridis. Emerging treatments in chronic hepatitis B. Expert Opinion on Emerging Drugs 2004; 9(2) doi: 10.1517/14728214.9.2.207
9	Jing You, Lin Zhuang, Hong-Ying Cheng, Shou-Ming Yan, Lan Yu, Jun-Hua Huang, Bao-Zhang Tang, Meng-Ling Huang, Yong-Liang Ma, Virasakdi Chongsuvivatwong, Hutcha Sriplung, Alan Geater, Yan-Wei Qiao, Rong-Xue Wu. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: A randomized controlled study. World Journal of Gastroenterology 2006; 12(41): 6715-6721 doi: 10.3748/wjg.v12.i41.6715 Abstract(1248) \| Core Tip(1110) \| Full Article(HTML)(3802) \| Full Article (PDF)-825K(527) \| Times Cited (38) \| Total Visits (5330) \| Open
10	Bo Hyun Kim, Youn-Jae Lee, Won Kim, Jung-Hwan Yoon, Eun Uk Jung, Sung Jae Park, Yoon Jun Kim, Hyo-Suk Lee. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study. Scandinavian Journal of Gastroenterology 2012; 47(8-9) doi: 10.3109/00365521.2012.694902
11	Pei Fu Chen, Geng Feng Fu, Hong Ying Zhang, Gen Xing Xu, Ya Yi Hou. Liposomal plasmid DNA encoding human thymosin α1 and interferon ω1 potently inhibits liver tumor growth in ICR mice. Journal of Gastroenterology and Hepatology 2006; 21(10) doi: 10.1111/j.1440-1746.2006.04536.x
12	Zheng-Wen Liu, Qun-Ying Han, Ni Zhang, Wen Kang. Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B. World Journal of Gastroenterology 2004; 10(7): 972-976 doi: 10.3748/wjg.v10.i7.972 Abstract(1398) \| Core Tip(1286) \| Full Article(HTML)(2840) \| Full Article (PDF)-125K(441) \| Times Cited (6) \| Total Visits (4327) \| Open
13	Rong-Nan Chien, Yun-Fan Liaw. Thymalfasin for the treatment of chronic hepatitis B. Expert Review of Anti-infective Therapy 2004; 2(1) doi: 10.1586/14787210.2.1.9
14	Raymund R. Razonable, James M. McGill. Hepatitis Prevention and Treatment. 2004; doi: 10.1007/978-3-0348-7903-3_10
15	Guo-Liang Zhang, Ye-Hong Wang, Wei Ni, Zhi-Bin Lin, Hui-Ling Teng. Hepatoprotective role of <italic>ganoderma lucidum</italic> polysaccharide against BCG-induced immune liver injury in mice. World Journal of Gastroenterology 2002; 8(4): 728-733 doi: 10.3748/wjg.v8.i4.728 Abstract(1598) \| Core Tip(1250) \| Full Article(HTML)(6285) \| Full Article (PDF)-1303K(827) \| Times Cited (0) \| Total Visits (8112) \| Open
16	R‐N. Chien, C‐Y. Lin, C‐T. Yeh, Y‐F. Liaw. Hepatitis B virus genotype B is associated with better response to thymosin α1 therapy than genotype C. Journal of Viral Hepatitis 2006; 13(12) doi: 10.1111/j.1365-2893.2006.00761.x
17	Yong-Feng Yang, Wei Zhao, Yan-Dan Zhong, Yi-Jun Yang, Ling Shen, Ning Zhang, Ping Huang. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis. Antiviral Research 2008; 77(2) doi: 10.1016/j.antiviral.2007.10.014

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.